Enzo Biochem (NYSE: ENZ) reported Q1 EPS of ($0.05), in-line with the analyst estimate of ($0.05). Revenue for the quarter came in at $25.2 million versus the consensus estimate of $25 million.

For earnings history and earnings-related data on Enzo Biochem (ENZ) click here.